$ cat ./records/pledged-50-million-to-renew-gates-foundation-tsinghua-ghddi-partn-2023.txt
Pledged $50 million to renew Gates Foundation-Tsinghua GHDDI partnership during Beijing visit
[RECORD.TXT] · cat --full
During Gates's June 2023 visit to Beijing — which also included his meeting with President Xi Jinping — the Gates Foundation announced a renewed five-year commitment of $50 million to GHDDI at Tsinghua University, matched by the Beijing Municipal Government. The renewed partnership extended GHDDI's work on tuberculosis drug discovery, added infectious disease modeling, and expanded AI-assisted drug screening capabilities. The announcement reflected Gates's determination to maintain scientific collaboration with Chinese institutions even amid deteriorating U.S.-China diplomatic relations.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Met Chinese President Xi Jinping in Beijing — welcomed as 'my old friend'
Next →
Addressed World Economic Forum on pandemic preparedness and health system resilience
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.